Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Agilent's Clinical Research Exome; Qiagen's GeneRead Panels; More


Agilent Technologies has launched its SureSelect Clinical Research Exome, which it developed in collaboration with researchers from Emory University and the Children’s Hospital of Philadelphia. It uses Agilent's SureSelect Human All Exon V5 as the core, but includes 10 percent deeper coverage and enhanced performance in disease-associated regions, including targets identified in OMIM, HGMD, and ClinVar databases. The kit targets around 54 mb of content.

Qiagen has launched 14 GeneRead DNAseq V2 cancer gene panels that encompass 570 clinically relevant cancer genes. The panels are customizable to include other genes or gene regions of clinical or biological interest and are compatible with any NGS sequencer, according to the company. There are three categories of panels: focused panels containing eight to 25 genes, disease-specific panels for 40-50 genes, and comprehensive panels containing as many as 160 genes.

Enzymatics has launched its Archer FusionPlex Sarcoma Panel, which detects and identifies fusions of 26 genes associated with soft tissue cancers. The panel uses Archer's proprietary Anchored Multiplex PCR enrichment technology to identify gene fusions in a single sequencing assay.

Multiplicom has launched its STARGARDT MASTR assay, a next-generation sequencing-based test for Stargardt disease. The assay amplifies the coding regions of the ABCA4, ELOVL4 AND CNGB3 genes. The assay contains 91 amplicons (300 -430 bp) amplified in four multiplex PCR reactions.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.